Pediatrics in New Jersey

Caregility Corporation is an enterprise telehealth and virtual care platform provider serving healthcare systems, hospitals, and care facilities across inpatient, outpatient, and home settings. Founded in 2011, the company delivers the Caregility Connected Care™ Platform, a cloud-based ecosystem that integrates AI-powered clinical workflows, virtual nursing, bedside sensors, and secure video collaboration tools. The platform enables virtual care delivery across emergency departments, ICUs, operating rooms, observation units, behavioral health, neonatal care, and long-term care environments. With deployments in over 1,100 hospitals across 85+ health systems, Caregility facilitates more than 6 million virtual sessions annually. The platform addresses critical healthcare challenges including clinician shortages, geographic access barriers, and operational inefficiency through features such as real-time clinical collaboration, remote patient monitoring, automated workflow support, and integrated analytics. Caregility emphasizes 99.99% platform availability, HIPAA compliance, ISO 27001/27701 certification, and 24/7 expert support, positioning itself as a mission-critical infrastructure provider for hospital networks seeking to scale virtual care at enterprise scale.

CozeeCoo, LLC manufactures the CozeeCoo®, a wearable infant positioning blanket and FDA-registered Class I medical device designed to prevent self-interference at the chest and above in infants aged newborn to 15 months. The product is engineered to deter hand contact with post-procedure medical sites, medical devices, topical medications, and areas affected by severe skin irritation or repetitive hand contact (such as eczema, cleft lip/palate recovery, or surgical sites). Made from Global Organic Textile Standard (GOTS) certified 100% organic cotton with hypoallergenic properties (free from nickel, toxic dyes, bleach, formaldehyde, and fragrances), the garment is washer, iron, and dryer safe. The CozeeCoo® features mobile arms that allow limb and body movement while restricting access to the chest area, and is suitable for use during sleep, diaper changes, and in standard car seats. The device is labeled with Unique Device Identification (UDI) barcodes for improved patient safety and surveillance. CozeeCoo® is FDA-listed and registered in the United States; sold internationally as a wearable baby blanket. The company offers multiple size options (Newborn/Preemie through 12-15 months) based on WHO child growth standards. Eligible for HSA/FSA/HRA reimbursement with a Letter of Medical Necessity. Fulfillment center located in New Jersey; ships globally via DHL, UPS, and USPS. Product launched March 2021; recognized as a TIME Best Invention 2023. Healthcare facility partnerships available; product is stocked in pediatric hospitals across the United States.

Oticon Medical is a manufacturer of bone-anchored hearing systems (BAHS) and bone conduction hearing solutions for children and adults with conductive, mixed, or single-sided sensorineural hearing loss. The company is part of the Demant Group and develops implantable and non-invasive hearing devices that bypass damaged portions of the ear to deliver sound directly to the inner ear via bone conduction. Primary product lines include the Ponto system (bone-conduction hearing processors available in multiple generations including Ponto 5 and Ponto 5 SuperPower), the Sentio transcutaneous system, and the Softband for pediatric candidates. Oticon Medical serves audiologists, hearing healthcare professionals, and patients globally through a network of local clinics and representatives. The company provides clinical support, online resources, batteries, and counseling tools through bahsjourney.com. Following the sale of their cochlear implant business in 2024, Oticon Medical remains focused exclusively on bone-anchored hearing aid development and patient support. Products are designed for implantation or transcutaneous use and marketed for use in educational, professional, and social settings. The company maintains regulatory compliance and operates through a global distribution network with localized support in multiple countries including the United States.

Laxmi Dental Lab USA Inc. is a well-equipped full-service dental laboratory offering superior-quality custom-made dental prostheses and branded dental products. Operating as part of Laxmi Dental Limited, a vertically integrated global dental products company with over 20 years of brand presence, the company serves dental professionals and clinics across 95+ countries. Laxmi Dental Lab USA operates Solitaire Smile Dental Lab, a full-service facility in New Jersey, providing custom crowns and bridges, clear aligner solutions, thermoforming sheets, and pediatric dental products. The parent company is among India's top two largest dental laboratories by revenue (FY2023) and the largest exporter of dental laboratory products by export value. The company maintains FDA 510(k) clearance for clear aligners (Illusion Aligners brand) and operates with robust technologically advanced capabilities including digital dentistry infrastructure and 3D printing capabilities for biocompatible resins. Product portfolio includes Illusion Zirconia premium dental crowns, Illusion clear aligners, Taglus thermoforming sheets and machines, and Kids-e-Dental pediatric prostheses. The organization is committed to stringent regulatory compliance and high quality standards across manufacturing and service operations, serving both domestic and international markets through integrated laboratory and export divisions.

Onkos Surgical is a precision orthopedic implant and surgical solutions company specializing in patient-matched, personalized approaches to complex bone and soft tissue reconstruction. The company serves over 350 leading academic medical institutions across the United States, focusing on oncologic and complex orthopedic cases including limb salvage, tumor reconstruction, and joint preservation. Onkos' core offerings include the ELEOS™ Limb Salvage System featuring BioGrip® Technology—a 3D-printed implant design addressing soft tissue and implant loosening failures—and the My3D® Personalized Solutions platform, a digital patient-matched system providing pre-operative planning, 3D visualization, graft-matching services, and comprehensive instrumentation. The company also manufactures the JTS (Juvenile Tumor System), an extendible implant for pediatric bone tumor patients that lengthens as the child grows. A key innovation is NanoCept®, the first FDA-granted antibacterial coating technology for orthopedic implants, demonstrated to protect implants from bacterial contamination at the time of surgery prior to implantation. The company emphasizes surgeon-driven, patient-inspired design reducing surgical complexity while driving personalization and addressing clinical challenges. Onkos combines virtual surgical planning, 3D modeling and printing, implant design, and workflow optimization to support improved patient outcomes. The company is actively engaged in post-market surveillance studies and has opened a dedicated Innovation Center for NanoCept® antibacterial technology development and manufacturing.

Olleyes, Inc. is a medical device company specializing in portable, virtual reality-based diagnostic platforms for eye care practices. Founded by Dr. Alberto Gonzalez-Garcia, Olleyes develops FDA-registered Class I medical devices that enable rapid, portable visual field testing and comprehensive ophthalmic assessments. The flagship VisuALL platform features ultra-high-definition (4K) resolution, a proprietary eye-tracking algorithm (Dynamic Matrix) that minimizes fixation loss, and support for pediatric-optimized testing protocols. The system offers multiple diagnostic tests including visual field (24-2, 10-2, 30-2 protocols), visual acuity, color vision, contrast sensitivity, pupillometry, and extraocular motility assessment. Olleyes provides three main product variants: VisuALL S (basic office use), VisuALL ETS (comprehensive with eye tracking and automated examination suite), and VisuALL C (screening device). The company also offers HearALL for additional diagnostics and TechALL, a virtual reality platform for remote ophthalmic technician support. All products integrate seamlessly with existing office IT infrastructure and support both in-office and at-home evaluations for conditions including glaucoma and age-related macular degeneration.